Exagen inc. prices public offering of common stock

Carlsbad, calif., may 08, 2025 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today announced the pricing of its previously announced underwritten public offering of 3,350,000 shares of its common stock at a public offering price of $5.25 per share.
XGN Ratings Summary
XGN Quant Ranking